Siegfried Successfully Issues Two Hybrid Convertible Bonds in the Amount of 80 Million Swiss Francs Montag, 28. Dezember 2020 - 18:20

As announced earlier, EGS Beteiligungen AG will participate in the financing of Siegfried’s acquisition of two Novartis pharmaceutical production sites in Spain through two hybrid convertible bonds issued by Siegfried.

The bonds entitle EGS Beteiligungen AG to convert the principal amount of 80 million Swiss Francs in total within 5 years into shares of Siegfried Holding AG (SIX:SFZN) should certain conversion conditions be met. In case of a conversion, and including the shares already held by EGS Beteiligungen AG today, this would result in a stake in Siegfried`s share capital of about 6.6 percent. The additionally required shares will come from treasury shares held by Siegfried already today. A capital increase is not planned in this context.  

As of today, all conditions required for a formal closing of the transaction with Novartis have been met. A separate announcement concerning the closing of the transaction is expected to be issued in the first days of January 2021.